NEW YORK, May 16, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP) (“Immune” or the “Company”) announced financial results for the first quarter ended March 31, 2016. Business and Research & Development (“R&D”) Update Immune continues to pursue its strategy to unlock the value of its diversified pipeline through the development, financing and strategic partnering of…